Consultation on transparency in clinical trials

21 January 2015

The European Medicines Agency (EMA) has launched a public consultation on how to implement the transparency requirements of the new EU Clinical Trials Regulation. The requirements must be implemented in the database for clinical trials, which the EMA is establishing together with the member states.

Draft proposal for an addendum, on transparency, to the “functional specifications for the EMA portal and EU database to be audited

EMA's press release

Deadline 18 February

All stakeholders are invited to send comments using this template to Send an email by close of business on 18 February 2015.

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.